샘플 요청 목록

 카트 문의
시장보고서
상품코드
1643372

세계의 풍선판막성형술 기기 시장

Balloon Valvuloplasty Devices
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 277 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

풍선판막성형술 기기 세계 시장은 2030년까지 27억 달러에 달할 전망

2024년에 23억 달러로 추정되는 풍선판막성형술 기기 세계 시장은 2024-2030년 분석 기간 동안 CAGR 2.8%로 성장하여 2030년에는 27억 달러에 달할 것으로 예상됩니다. 본 보고서에서 분석한 부문 중 하나인 대동맥판막 협착증 애플리케이션은 CAGR 2.4%를 기록하여 분석 기간 종료 시점에 17억 달러에 도달할 것으로 예상됩니다. 폐동맥판 협착증 애플리케이션 부문의 성장률은 분석 기간 동안 CAGR 3.4%로 추정됩니다.

미국 시장 6억 2,370만 달러로 추정, 중국은 CAGR 5.2%로 성장 전망

미국의 풍선판막성형술 기기 시장은 2024년 6억 2,370만 달러로 추정됩니다. 세계 2위의 경제 대국인 중국은 2024-2030년 분석 기간 동안 5.2%의 CAGR로 2030년까지 5억 2,200만 달러의 시장 규모에 도달할 것으로 예측됩니다. 다른 주목할 만한 지역 시장으로는 일본과 캐나다가 분석 기간 동안 각각 1.1%와 2.1%의 CAGR을 기록할 것으로 예측됩니다. 유럽에서는 독일이 CAGR 1.5%로 성장할 것으로 예상됩니다.

세계 풍선판막성형술 기기 시장 - 주요 동향 및 촉진요인 정리

최소침습 수술의 발전은 어떻게 보급을 촉진하고 있는가?

최소침습적 치료에 대한 선호도가 높아지면서 풍선판막성형술에 대한 수요가 크게 증가하고 있습니다. 이 장치는 대동맥판막 협착증, 승모판막 협착증과 같은 심장판막 질환의 치료에 널리 사용되고 있으며, 개심술을 대체할 수 있는 최소침습적 치료법입니다. 풍선판막 성형술의 최소침습성은 회복 시간 단축, 합병증 위험 감소, 환자 예후 개선으로 이어져 의료진과 환자들 사이에서 선호되고 있습니다.

풍선판막성형술 기기에서는 카테터 디자인 개선, 영상 유도 강화, 정확한 풍선 크기 조정 등의 기술 혁신이 풍선판막성형술의 채택에 더욱 기여하고 있습니다. 이러한 발전으로 심장 전문의는 복잡한 경우에도 정확하고 효과적인 시술을 할 수 있게 되었습니다. 그 결과, 심혈관질환의 유병률 증가와 고급 치료 옵션의 필요성에 힘입어 이러한 장비에 대한 수요는 계속 증가할 것으로 예상됩니다.

심장판막증 유병률 증가가 시장 촉진요인인 이유는 무엇인가?

심장판막 질환의 유병률 증가, 특히 고령화 인구의 증가는 풍선판막성형술 기기 시장의 성장을 촉진하는 중요한 요인입니다. 대동맥판막 협착증, 승모판막 폐쇄부전증과 같은 질환은 전 세계적으로 평균 수명이 증가함에 따라 점점 더 흔해지고 있습니다. 이러한 질환은 심부전, 뇌졸중, 갑작스런 심장마비와 같은 합병증을 예방하기 위해 적시에 의료 개입이 필요한 경우가 많습니다.

풍선판막 성형술은 특히 수술적 판막 치환술이 적합하지 않은 고위험군 환자에게는 매우 유용한 치료 옵션입니다. 이 때문에 전 세계 의료 기관에서 풍선판막성형술을 도입하여 효과적인 치료를 받을 수 있게 되었습니다. 또한, 판막 질환의 조기 진단 및 치료에 대한 인식이 높아지면서 더 많은 환자들이 의료 기관을 찾게 되어 풍선판막 성형술 장비 시장이 성장하고 있습니다.

기술의 발전은 어떻게 장비의 효율성을 향상시키고 있는가?

풍선판막성형술 기기의 기술 발전으로 효율성과 안전성이 크게 향상되었습니다. 각 제조업체는 고압 풍선, 높은 기동성, 영상 시스템과의 호환성 향상 등의 특징을 갖춘 차세대 장치 개발에 주력하고 있습니다. 이러한 개선사항은 정확한 삽입과 확장을 가능하게 하여 주변 조직 손상의 위험을 최소화할 수 있도록 도와줍니다.

또한, 실시간 영상 및 내비게이션 시스템과 같은 디지털 도구의 통합은 시술의 정확성에 혁명을 일으키고 있습니다. 이러한 도구는 임상의가 시술 중 기기를 시각화하고 안내하여 최적의 결과를 보장할 수 있도록 도와줍니다. 또한 생체적합성 폴리머 및 유연한 디자인과 같은 재료의 혁신은 환자의 편안함을 개선하고 시술 후 합병증 발생 가능성을 감소시키고 있습니다. 이러한 기술적 발전은 풍선판막성형술의 효능을 향상시킬 뿐만 아니라, 더 많은 환자들에게 적용될 수 있도록 확장하고 있습니다.

풍선판막성형술 기기 시장의 성장을 촉진하는 요인은 무엇인가?

풍선판막성형술 기기 시장의 성장은 심장판막 질환의 유병률 증가, 최소침습적 기술의 발전, 장치 효율성의 지속적인 개선 등 여러 가지 요인에 의해 주도되고 있습니다. 전 세계적으로 고령화와 이에 따른 심혈관질환의 증가로 효과적인 치료 옵션에 대한 긴급한 요구가 증가하고 있으며, 풍선판막 성형술은 중요한 치료법이 되고 있습니다.

소비자 행동, 특히 회복 시간이 짧은 최소침습 수술에 대한 수요 증가가 시장 역학을 형성하고 있습니다. 첨단 영상 유도 및 카테터 디자인 개선과 같은 기술 혁신은 시술 결과를 향상시킴으로써 시장 확대를 더욱 촉진하고 있습니다. 또한, 의료 인프라에 대한 투자 증가와 판막증에 대한 조기 개입의 이점에 대한 인식이 높아짐에 따라 보급을 촉진하고 있습니다. 이러한 요인들은 세계 풍선판막성형술 기기 시장의 견고한 성장 궤적을 뒷받침하고 있습니다.

부문

용도(대동맥판막협착증 용도, 폐동맥판막협착증 용도), 최종 용도(병원 최종 용도, 외래 수술 센터 최종 용도, 심장 카테터 검사실 최종 용도)

조사 대상 기업 예시(43개사)

  • B. Braun Interventional Systems, Inc.
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • BrosMed Medical Company Limited
  • Edwards Lifesciences Corporation
  • Getinge AB(Getinge Group)
  • Koninklijke Philips NV
  • Medtronic Plc
  • Stryker Corporation
  • Terumo Corporation

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 성장 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

ksm 25.02.13

Global Balloon Valvuloplasty Devices Market to Reach US$2.7 Billion by 2030

The global market for Balloon Valvuloplasty Devices estimated at US$2.3 Billion in the year 2024, is expected to reach US$2.7 Billion by 2030, growing at a CAGR of 2.8% over the analysis period 2024-2030. Aortic Valve Stenosis Application, one of the segments analyzed in the report, is expected to record a 2.4% CAGR and reach US$1.7 Billion by the end of the analysis period. Growth in the Pulmonary Valve Stenosis Application segment is estimated at 3.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$623.7 Million While China is Forecast to Grow at 5.2% CAGR

The Balloon Valvuloplasty Devices market in the U.S. is estimated at US$623.7 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$522.0 Million by the year 2030 trailing a CAGR of 5.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.1% and 2.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.5% CAGR.

Global Balloon Valvuloplasty Devices Market - Key Trends & Drivers Summarized

How Are Advancements in Minimally Invasive Procedures Driving Adoption?

The growing preference for minimally invasive procedures is significantly propelling the demand for balloon valvuloplasty devices. These devices are widely used in the treatment of valvular heart diseases, such as aortic stenosis and mitral stenosis, offering a less invasive alternative to open-heart surgery. The minimally invasive nature of balloon valvuloplasty results in reduced recovery times, lower risk of complications, and improved patient outcomes, making it a preferred choice among healthcare providers and patients.

Technological innovations in balloon valvuloplasty devices, such as improved catheter designs, enhanced imaging guidance, and precise balloon sizing, are further contributing to their adoption. These advancements enable cardiologists to perform highly accurate and effective procedures, even in complex cases. As a result, the demand for these devices is expected to continue its upward trajectory, driven by the increasing prevalence of cardiovascular diseases and the need for advanced treatment options.

Why Is the Rising Prevalence of Valvular Heart Diseases a Key Market Driver?

The rising prevalence of valvular heart diseases, particularly among the aging population, is a critical factor driving the growth of the balloon valvuloplasty devices market. Conditions such as aortic stenosis and mitral regurgitation are becoming increasingly common as global life expectancy improves. These diseases often require timely medical intervention to prevent complications such as heart failure, stroke, or sudden cardiac arrest.

Balloon valvuloplasty is a valuable treatment option, especially for high-risk patients who are not candidates for surgical valve replacement. This has spurred healthcare facilities worldwide to adopt these devices, ensuring access to effective therapies. Additionally, increasing awareness about early diagnosis and treatment of valvular conditions is encouraging more patients to seek medical attention, thereby boosting the market for balloon valvuloplasty devices.

How Are Technological Advancements Improving Device Efficiency?

Technological advancements in balloon valvuloplasty devices are significantly enhancing their efficiency and safety. Manufacturers are focusing on developing next-generation devices with features such as high-pressure balloons, advanced steerability, and enhanced compatibility with imaging systems. These improvements enable precise placement and dilation, minimizing the risk of damage to surrounding tissues.

Moreover, the integration of digital tools, such as real-time imaging and navigation systems, is revolutionizing procedural accuracy. These tools allow clinicians to visualize and guide the device during the procedure, ensuring optimal outcomes. Additionally, innovations in materials, such as biocompatible polymers and flexible designs, are improving patient comfort and reducing the likelihood of post-procedure complications. These technological strides are not only enhancing the efficacy of balloon valvuloplasty but also expanding its application across a broader patient population.

What Factors Are Driving the Growth of the Balloon Valvuloplasty Devices Market?

The growth in the balloon valvuloplasty devices market is driven by several factors, including the increasing prevalence of valvular heart diseases, advancements in minimally invasive technologies, and ongoing improvements in device efficiency. The aging global population and the associated rise in cardiovascular conditions have created a pressing need for effective treatment options, making balloon valvuloplasty a critical intervention.

Consumer behavior, particularly the growing demand for minimally invasive procedures with shorter recovery times, is shaping market dynamics. Technological innovations, such as advanced imaging guidance and improved catheter designs, are further supporting market expansion by enhancing procedural outcomes. Additionally, increased investment in healthcare infrastructure and rising awareness about the benefits of early intervention in valvular diseases are driving adoption. These factors collectively underscore the robust growth trajectory of the global balloon valvuloplasty devices market.

SCOPE OF STUDY:

The report analyzes the Balloon Valvuloplasty Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Application (Aortic Valve Stenosis Application, Pulmonary Valve Stenosis Application); End-Use (Hospitals End-Use, Ambulatory Surgery Centers End-Use, Cardiac Catheterization Labs End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 43 Featured) -

  • B. Braun Interventional Systems, Inc.
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • BrosMed Medical Company Limited
  • Edwards Lifesciences Corporation
  • Getinge AB (Getinge Group)
  • Koninklijke Philips NV
  • Medtronic Plc
  • Stryker Corporation
  • Terumo Corporation

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Economic Frontiers: Trends, Trials & Transformations
    • Balloon Valvuloplasty Devices - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Valvular Heart Diseases Spurs Demand for Balloon Valvuloplasty Devices
    • Technological Advancements in Minimally Invasive Cardiac Procedures Strengthen Market Growth
    • Increasing Geriatric Population Expands Addressable Market for Balloon Valvuloplasty Solutions
    • Growing Adoption of Catheter-Based Interventions Drives Demand for Advanced Valvuloplasty Devices
    • Expanding Healthcare Infrastructure in Emerging Markets Propels Market Opportunities
    • Rising Awareness About Minimally Invasive Treatment Options Accelerates Adoption Rates
    • Integration of Imaging Technologies with Valvuloplasty Devices Enhances Procedural Accuracy
    • Government Initiatives and Funding for Cardiovascular Health Strengthen Market Demand
    • Increasing Availability of Reimbursement Policies Supports Market Expansion
    • Surge in Demand for Outpatient Procedures Fuels Growth in Ambulatory Surgical Centers
    • High Burden of Congenital Heart Defects Drives Demand for Pediatric Balloon Valvuloplasty Devices
    • Innovations in Balloon Materials and Coatings Improve Device Performance and Durability
    • Expanding Focus on Personalized and Patient-Centric Treatment Approaches Drives Demand
    • Challenges in Open-Heart Surgery Propel Shift Toward Less Invasive Procedures
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Balloon Valvuloplasty Devices Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Balloon Valvuloplasty Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Balloon Valvuloplasty Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Aortic Valve Stenosis Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Aortic Valve Stenosis Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Aortic Valve Stenosis Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Pulmonary Valve Stenosis Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Pulmonary Valve Stenosis Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Pulmonary Valve Stenosis Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Ambulatory Surgery Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Cardiac Catheterization Labs End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Cardiac Catheterization Labs End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Cardiac Catheterization Labs End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Balloon Valvuloplasty Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: USA 15-Year Perspective for Balloon Valvuloplasty Devices by Application - Percentage Breakdown of Value Sales for Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application for the Years 2015, 2025 & 2030
    • TABLE 23: USA Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: USA 15-Year Perspective for Balloon Valvuloplasty Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: Canada 15-Year Perspective for Balloon Valvuloplasty Devices by Application - Percentage Breakdown of Value Sales for Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application for the Years 2015, 2025 & 2030
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: Canada 15-Year Perspective for Balloon Valvuloplasty Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use for the Years 2015, 2025 & 2030
  • JAPAN
    • Balloon Valvuloplasty Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: Japan 15-Year Perspective for Balloon Valvuloplasty Devices by Application - Percentage Breakdown of Value Sales for Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application for the Years 2015, 2025 & 2030
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: Japan 15-Year Perspective for Balloon Valvuloplasty Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use for the Years 2015, 2025 & 2030
  • CHINA
    • Balloon Valvuloplasty Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 38: China Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: China Historic Review for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: China 15-Year Perspective for Balloon Valvuloplasty Devices by Application - Percentage Breakdown of Value Sales for Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application for the Years 2015, 2025 & 2030
    • TABLE 41: China Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: China 15-Year Perspective for Balloon Valvuloplasty Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use for the Years 2015, 2025 & 2030
  • EUROPE
    • Balloon Valvuloplasty Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Balloon Valvuloplasty Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Europe 15-Year Perspective for Balloon Valvuloplasty Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Europe 15-Year Perspective for Balloon Valvuloplasty Devices by Application - Percentage Breakdown of Value Sales for Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application for the Years 2015, 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Europe 15-Year Perspective for Balloon Valvuloplasty Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use for the Years 2015, 2025 & 2030
  • FRANCE
    • Balloon Valvuloplasty Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 53: France Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: France Historic Review for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: France 15-Year Perspective for Balloon Valvuloplasty Devices by Application - Percentage Breakdown of Value Sales for Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application for the Years 2015, 2025 & 2030
    • TABLE 56: France Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: France 15-Year Perspective for Balloon Valvuloplasty Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use for the Years 2015, 2025 & 2030
  • GERMANY
    • Balloon Valvuloplasty Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 59: Germany Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Germany Historic Review for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Germany 15-Year Perspective for Balloon Valvuloplasty Devices by Application - Percentage Breakdown of Value Sales for Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application for the Years 2015, 2025 & 2030
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Germany 15-Year Perspective for Balloon Valvuloplasty Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 65: Italy Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Italy Historic Review for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Italy 15-Year Perspective for Balloon Valvuloplasty Devices by Application - Percentage Breakdown of Value Sales for Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application for the Years 2015, 2025 & 2030
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Italy 15-Year Perspective for Balloon Valvuloplasty Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Balloon Valvuloplasty Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 71: UK Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: UK Historic Review for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: UK 15-Year Perspective for Balloon Valvuloplasty Devices by Application - Percentage Breakdown of Value Sales for Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application for the Years 2015, 2025 & 2030
    • TABLE 74: UK Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: UK 15-Year Perspective for Balloon Valvuloplasty Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 77: Spain Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Spain Historic Review for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Spain 15-Year Perspective for Balloon Valvuloplasty Devices by Application - Percentage Breakdown of Value Sales for Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application for the Years 2015, 2025 & 2030
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Spain 15-Year Perspective for Balloon Valvuloplasty Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 83: Russia Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Russia Historic Review for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Russia 15-Year Perspective for Balloon Valvuloplasty Devices by Application - Percentage Breakdown of Value Sales for Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application for the Years 2015, 2025 & 2030
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Russia 15-Year Perspective for Balloon Valvuloplasty Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Rest of Europe 15-Year Perspective for Balloon Valvuloplasty Devices by Application - Percentage Breakdown of Value Sales for Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application for the Years 2015, 2025 & 2030
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Rest of Europe 15-Year Perspective for Balloon Valvuloplasty Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Balloon Valvuloplasty Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for Balloon Valvuloplasty Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Asia-Pacific 15-Year Perspective for Balloon Valvuloplasty Devices by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 15-Year Perspective for Balloon Valvuloplasty Devices by Application - Percentage Breakdown of Value Sales for Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application for the Years 2015, 2025 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for Balloon Valvuloplasty Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Balloon Valvuloplasty Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 104: Australia Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Australia Historic Review for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Australia 15-Year Perspective for Balloon Valvuloplasty Devices by Application - Percentage Breakdown of Value Sales for Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application for the Years 2015, 2025 & 2030
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Australia 15-Year Perspective for Balloon Valvuloplasty Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use for the Years 2015, 2025 & 2030
  • INDIA
    • Balloon Valvuloplasty Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 110: India Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: India Historic Review for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: India 15-Year Perspective for Balloon Valvuloplasty Devices by Application - Percentage Breakdown of Value Sales for Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application for the Years 2015, 2025 & 2030
    • TABLE 113: India Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: India 15-Year Perspective for Balloon Valvuloplasty Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 116: South Korea Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: South Korea Historic Review for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: South Korea 15-Year Perspective for Balloon Valvuloplasty Devices by Application - Percentage Breakdown of Value Sales for Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application for the Years 2015, 2025 & 2030
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: South Korea 15-Year Perspective for Balloon Valvuloplasty Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 122: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Rest of Asia-Pacific Historic Review for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: Rest of Asia-Pacific 15-Year Perspective for Balloon Valvuloplasty Devices by Application - Percentage Breakdown of Value Sales for Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application for the Years 2015, 2025 & 2030
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 15-Year Perspective for Balloon Valvuloplasty Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Balloon Valvuloplasty Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 128: Latin America Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 129: Latin America Historic Review for Balloon Valvuloplasty Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Latin America 15-Year Perspective for Balloon Valvuloplasty Devices by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Latin America 15-Year Perspective for Balloon Valvuloplasty Devices by Application - Percentage Breakdown of Value Sales for Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application for the Years 2015, 2025 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Latin America 15-Year Perspective for Balloon Valvuloplasty Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 137: Argentina Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Argentina Historic Review for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Argentina 15-Year Perspective for Balloon Valvuloplasty Devices by Application - Percentage Breakdown of Value Sales for Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application for the Years 2015, 2025 & 2030
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Argentina 15-Year Perspective for Balloon Valvuloplasty Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 143: Brazil Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Brazil Historic Review for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Brazil 15-Year Perspective for Balloon Valvuloplasty Devices by Application - Percentage Breakdown of Value Sales for Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application for the Years 2015, 2025 & 2030
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Brazil 15-Year Perspective for Balloon Valvuloplasty Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 149: Mexico Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Mexico Historic Review for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Mexico 15-Year Perspective for Balloon Valvuloplasty Devices by Application - Percentage Breakdown of Value Sales for Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application for the Years 2015, 2025 & 2030
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Mexico 15-Year Perspective for Balloon Valvuloplasty Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 155: Rest of Latin America Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Rest of Latin America Historic Review for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Rest of Latin America 15-Year Perspective for Balloon Valvuloplasty Devices by Application - Percentage Breakdown of Value Sales for Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application for the Years 2015, 2025 & 2030
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Rest of Latin America 15-Year Perspective for Balloon Valvuloplasty Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Balloon Valvuloplasty Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 161: Middle East Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 162: Middle East Historic Review for Balloon Valvuloplasty Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Middle East 15-Year Perspective for Balloon Valvuloplasty Devices by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Middle East 15-Year Perspective for Balloon Valvuloplasty Devices by Application - Percentage Breakdown of Value Sales for Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application for the Years 2015, 2025 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: Middle East 15-Year Perspective for Balloon Valvuloplasty Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 170: Iran Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Iran Historic Review for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: Iran 15-Year Perspective for Balloon Valvuloplasty Devices by Application - Percentage Breakdown of Value Sales for Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application for the Years 2015, 2025 & 2030
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: Iran 15-Year Perspective for Balloon Valvuloplasty Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 176: Israel Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Israel Historic Review for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: Israel 15-Year Perspective for Balloon Valvuloplasty Devices by Application - Percentage Breakdown of Value Sales for Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application for the Years 2015, 2025 & 2030
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: Israel 15-Year Perspective for Balloon Valvuloplasty Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 182: Saudi Arabia Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Saudi Arabia Historic Review for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: Saudi Arabia 15-Year Perspective for Balloon Valvuloplasty Devices by Application - Percentage Breakdown of Value Sales for Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application for the Years 2015, 2025 & 2030
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: Saudi Arabia 15-Year Perspective for Balloon Valvuloplasty Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 188: UAE Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: UAE Historic Review for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: UAE 15-Year Perspective for Balloon Valvuloplasty Devices by Application - Percentage Breakdown of Value Sales for Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application for the Years 2015, 2025 & 2030
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: UAE 15-Year Perspective for Balloon Valvuloplasty Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 194: Rest of Middle East Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Middle East Historic Review for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: Rest of Middle East 15-Year Perspective for Balloon Valvuloplasty Devices by Application - Percentage Breakdown of Value Sales for Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application for the Years 2015, 2025 & 2030
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: Rest of Middle East 15-Year Perspective for Balloon Valvuloplasty Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use for the Years 2015, 2025 & 2030
  • AFRICA
    • Balloon Valvuloplasty Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 200: Africa Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Africa Historic Review for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Africa 15-Year Perspective for Balloon Valvuloplasty Devices by Application - Percentage Breakdown of Value Sales for Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application for the Years 2015, 2025 & 2030
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Africa 15-Year Perspective for Balloon Valvuloplasty Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제